Erythromycin Injectable (Iv) 1 g/10 mL, 2 g/10 mL Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV)
Available Strengths: 1 g/10 mL, 2 g/10 mL
Reference Brands: Erythrocin, Erythrocin V, Erythrocin Stearate(US), Eritro (India)
Category: Antibiotics
Erythromycin IV inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation and bacterial growth. It provides rapid, effective treatment for severe respiratory, skin, and soft tissue infections. Benefits include broad-spectrum action, good tissue penetration, and reliable, quick bacterial eradication when administered under medical supervision.
Product Description:
Erythromycin IV is approved in both the EU and US for severe bacterial infections, including respiratory and skin infections. In the EU, brands like Erythrocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for erythromycin IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Erythromycin Injectable (Iv) — third party manufacturing & bulk supply
Erythromycin Injectable (Iv) 1 g/10 mL, 2 g/10 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Erythromycin Injectable (Iv) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Erythromycin Injectable (Iv) →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Erythromycin Injection is used to treat serious bacterial infections such as respiratory tract infections, skin and soft tissue infections, diphtheria, and pertussis (whooping cough). It is usually given when oral treatment is not suitable or when rapid treatment is required.
Erythromycin Injection is made from erythromycin, a macrolide antibiotic derived from the bacterium Streptomyces erythreus, along with suitable excipients for intravenous administration.
Common trade names include Erythrocin Injection and Erythrocin IV.
The original Erythrocin brand was developed by the pharmaceutical company Eli Lilly and Company, while many other pharmaceutical companies manufacture generic erythromycin injections worldwide.
The generic name is Erythromycin Injection.
Common brand names include Erythrocin Injection and Erythrocin IV.
Erythromycin Injection is manufactured in several countries including the United States, India, China, and European countries by different pharmaceutical manufacturers.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
